Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.

Sidwell RW, Huffman JH, Bailey KW, Wong MH, Nimrod A, Panet A.

Antimicrob Agents Chemother. 1996 Nov;40(11):2626-31.

2.

In vitro and in vivo influenza virus-inhibitory effects of viramidine.

Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF.

Antiviral Res. 2005 Oct;68(1):10-7.

PMID:
16087250
3.

Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.

Sidwell RW, Wong MH, Bailey KW, Barnard DL, Jackson MK, Smee DF.

Antivir Chem Chemother. 2001 Nov;12(6):359-65.

PMID:
12018681
4.

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.

Sidwell RW, Smee DF, Huffman JH, Barnard DL, Bailey KW, Morrey JD, Babu YS.

Antimicrob Agents Chemother. 2001 Mar;45(3):749-57.

5.

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.

Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T, Kim CU.

Antiviral Res. 1998 Feb;37(2):107-20.

PMID:
9588843
6.

Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.

Smee DF, Wandersee MK, Wong MH, Bailey KW, Sidwell RW.

Antivir Chem Chemother. 2004 Sep;15(5):261-8.

PMID:
15535048
7.

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

Sidwell RW, Smee DF, Huffman JH, Barnard DL, Morrey JD, Bailey KW, Feng WC, Babu YS, Bush K.

Antiviral Res. 2001 Sep;51(3):179-87.

PMID:
11448729
8.

In vivo anti-influenza virus activity of a zinc finger peptide.

Judd AK, Sanchez A, Bucher DJ, Huffman JH, Bailey K, Sidwell RW.

Antimicrob Agents Chemother. 1997 Mar;41(3):687-92.

9.

Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).

Sidwell RW, Bailey KW, Morrey JD, Wong MH, Baldwin TJ, Smee DF.

Antiviral Res. 2003 Sep;60(1):17-25.

PMID:
14516917
10.

Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.

Barnard DL, Wong MH, Bailey K, Day CW, Sidwell RW, Hickok SS, Hall TJ.

Antivir Chem Chemother. 2007;18(3):125-32.

PMID:
17626596
11.

Effect of selenazofurin on influenza A and B virus infections of mice.

Sidwell RW, Huffman JH, Call EW, Alaghamandan H, Cook PD, Robins RK.

Antiviral Res. 1986 Oct;6(6):343-53.

PMID:
3022644
12.
13.

Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid.

Sidwell RW, Huffman JH, Moscon BJ, Warren RP.

Chemotherapy. 1994 Jan-Feb;40(1):42-50.

PMID:
8306815
14.
15.

Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.

Sidwell RW, Barnard DL, Day CW, Smee DF, Bailey KW, Wong MH, Morrey JD, Furuta Y.

Antimicrob Agents Chemother. 2007 Mar;51(3):845-51. Epub 2006 Dec 28.

16.

In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin.

Sidwell RW, Bailey KW, Wong MH, Huffman JH.

Chemotherapy. 1995 Nov-Dec;41(6):455-61.

PMID:
8529436
17.

Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals.

Duan S, Gu L, Wang Y, Zheng R, Lu J, Yin J, Guli L, Ball M.

Am J Chin Med. 2009;37(6):1167-77.

PMID:
19938224
18.

Therapeutic effects of ribavirin given by the intraperitoneal or aerosol route against influenza virus infections in mice.

Stephen EL, Dominik JW, Moe JB, Walker JS.

Antimicrob Agents Chemother. 1976 Sep;10(3):549-54.

19.

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice.

Sidwell RW, Huffman JH, Gilbert J, Moscon B, Pedersen G, Burger R, Warren RP.

Antimicrob Agents Chemother. 1992 Feb;36(2):473-6.

20.

Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.

Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K.

PLoS One. 2012;7(8):e42419. doi: 10.1371/journal.pone.0042419. Epub 2012 Aug 1.

Supplemental Content

Support Center